HIGHLIGHTS
- who: Maria-Adriana Neag1 and colleagues from the Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatu0327ieganu University of Medicine and Pharmacy, and Technology, China have published the paper: miRNA Involvement in Cerebral Ischemia-Reperfusion Injury, in the Journal: (JOURNAL)
SUMMARY
Metabolic disruption of neurons activates immune_responses, resulting in a complex chain of molecular events, which further promote progressive cellular damage and irretrievable neuronal death (Moskowitz et_al, 2010; Khoshnam et_al, 2017). The standard therapeutic strategy for ischemic stroke remains thrombolytic reperfusion therapy provided by intravenous tissue plasminogen activator that is, however, limited by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.